Cambridge, Massachusetts, Feb. 04, 2026 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer’s disease ...
Cambridge, Massachusetts, Feb. 04, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer’s ...
Cambridge, Massachusetts, Feb. 04, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer's ...
The “Today” show anchor, in a message on social media with her siblings, said the return of their mother Nancy “is the only way we will have peace.” By Reis Thebault Reporting from Tucson, Ariz. In a ...
) has been revised to $105.95 / share. This is a decrease of 22.70% from the prior estimate of $137.06 dated January 11, 2026. The price target is an average of many targets provided by analysts. The ...
James Davolos, portfolio manager at Horizon Kinetics, sits down with InvestmentNews anchor Gregg Greenberg to discuss how the Inflation Beneficiaries ETF compares to other inflation fighting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results